BY MARC KAUFMAN
Washington Post Service
February 15, 2004
http://www.miami.com/mld/miamiherald/news/nation/7957766.htmWASHINGTON - The Drug Enforcement Administration is working to make one of the most widely prescribed medications more difficult for patients to obtain as part of its stepped-up offensive against the diversion and abuse of prescription painkillers.
Top DEA officials confirm that the agency is eager to change the official listing of the narcotic hydrocodone -- which was prescribed more than 100 million times last year -- to the highly restricted Schedule II category of the Controlled Substances Act. A painkiller and cough suppressant sold as Lortab, Vicodin and 200 generic brands, hydrocodone combined with other medications has long been available under the less stringent rules of Schedule III.
The DEA effort is part of a broad campaign to address the problem of prescription drug abuse. The initiative has repeatedly pitted the agency against doctors, pharmacists and pain sufferers, and it is doing so again with the hydrocodone proposal.
Pain specialists and pharmacy representatives say the new restrictions would be a burden on the millions of Americans who need the drug to treat serious pain from arthritis, AIDS, cancer and chronic injuries, and that many sufferers are likely to be prescribed other, less effective drugs as a result.
- more . . .
http://www.miami.com/mld/miamiherald/news/nation/7957766.htm